COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization-Reference-Cited by-同舟云学术

COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization

Published:2023-03 Issue:3 Volume:55 Page:316-321
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Stroffolini Tommaso,Ciancio Alessia,Federico Alessandro,Benigno Rosa G.,Colloredo Guido,Lombardi Anna,Niro Grazia Anna,Verucchi Gabriella,Ferrigno Luigina,Gioli Federico,Marignani Massimo^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference22 articles.

1. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study;Marjot;J Hepatol,2021

2. Outcome of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: a national COVID cohort collaborative study;Ge;Gastroenterology,2021

3. Cirrhosis associated immune dysfunction: distinctive features and clinical relevance;Albillos;J Hepatol,2014

4. Immune dysfunction and infections in patients with cirrhosis;Bonnel;Clin Gastroenterol Hepatol,2011

5. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Engl J Med,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination in Patients with Liver Cirrhosis: A Neglected Topic;Vaccines;2024-06-27

2. Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis;Human Vaccines & Immunotherapeutics;2024-03-11

3. Efficacy, immunogenicity, and safety of COVID-19 vaccines in individuals with liver cirrhosis: a rapid review and meta-analysis;Clinical and Experimental Vaccine Research;2024

4. Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant;Hepatology Communications;2023-10-18